A significant advance in cancer investigation is occurring with the use of nanobodies to re-engage mutated p53. This crucial malignant protector protein is frequently disabled in various kinds of tumors, causing https://totalbookmarking.com/story22005345/mini-antibodies-reactivate-p53-the-potential-approach-for-malignant-therapy